S
Seoulin Bioscience Co Ltd
KOSDAQ:038070
Seoulin Bioscience Co Ltd
KOSDAQ:038070
Price:
6 320
KRW
0.48%
Market Closed
Market Cap:
₩57.5B
Balance Sheet
Balance Sheet Decomposition
Seoulin Bioscience Co Ltd
Seoulin Bioscience Co Ltd
Balance Sheet Decomposition is not available for
Seoulin Bioscience Co Ltd
Seoulin Bioscience Co Ltd
Balance Sheet
Seoulin Bioscience Co Ltd
Seoulin Bioscience Co Ltd
Currency: KRW
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
1 961
|
3 871
|
2 585
|
3 685
|
4 806
|
3 420
|
3 805
|
4 543
|
8 498
|
14 973
|
8 999
|
14 602
|
8 949
|
|
| Cash |
2
|
3
|
5
|
4
|
2
|
0
|
3
|
3
|
4
|
0
|
3
|
3
|
3
|
|
| Cash Equivalents |
1 959
|
3 868
|
2 580
|
3 681
|
4 804
|
3 420
|
3 802
|
4 540
|
8 494
|
14 973
|
8 996
|
14 599
|
8 946
|
|
| Short-Term Investments |
15 731
|
20 107
|
19 249
|
19 409
|
10 961
|
7 398
|
5 675
|
16 797
|
10 362
|
58 309
|
43 795
|
18 276
|
13 409
|
|
| Total Receivables |
15 679
|
10 917
|
13 408
|
10 941
|
9 591
|
7 291
|
7 594
|
9 395
|
8 908
|
10 333
|
9 578
|
15 509
|
9 591
|
|
| Accounts Receivables |
15 496
|
10 725
|
13 151
|
10 691
|
9 275
|
7 291
|
7 547
|
9 365
|
8 897
|
10 287
|
9 478
|
14 589
|
9 277
|
|
| Other Receivables |
183
|
192
|
257
|
250
|
316
|
0
|
47
|
30
|
11
|
46
|
100
|
919
|
314
|
|
| Inventory |
4 111
|
5 011
|
4 171
|
6 410
|
9 725
|
13 283
|
15 109
|
12 030
|
11 748
|
13 933
|
17 307
|
21 785
|
26 245
|
|
| Other Current Assets |
118
|
147
|
255
|
831
|
937
|
557
|
586
|
1 038
|
1 946
|
3 298
|
7 607
|
2 783
|
1 647
|
|
| Total Current Assets |
37 600
|
40 054
|
39 668
|
41 276
|
36 020
|
31 950
|
32 770
|
43 803
|
41 462
|
100 846
|
87 287
|
72 955
|
59 841
|
|
| PP&E Net |
11 210
|
13 340
|
13 225
|
15 981
|
20 023
|
27 243
|
26 616
|
25 920
|
14 541
|
14 937
|
16 491
|
18 914
|
16 628
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25 920
|
14 541
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
27
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
815
|
789
|
1 032
|
1 032
|
2 493
|
4 049
|
2 827
|
2 285
|
2 035
|
789
|
478
|
581
|
503
|
|
| Goodwill |
0
|
526
|
526
|
1 166
|
1 166
|
0
|
1 166
|
526
|
526
|
526
|
526
|
526
|
374
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
40
|
18
|
0
|
|
| Long-Term Investments |
5 168
|
4 384
|
4 990
|
5 539
|
5 509
|
6 757
|
6 619
|
6 084
|
16 952
|
11 955
|
28 505
|
18 219
|
21 324
|
|
| Other Long-Term Assets |
1 835
|
1 293
|
1 277
|
1 110
|
1 259
|
1 039
|
1 113
|
2 089
|
2 731
|
7 513
|
2 160
|
2 886
|
2 855
|
|
| Other Assets |
0
|
526
|
526
|
1 166
|
1 166
|
0
|
1 166
|
526
|
526
|
526
|
526
|
526
|
374
|
|
| Total Assets |
56 628
N/A
|
60 387
+7%
|
60 718
+1%
|
66 104
+9%
|
66 470
+1%
|
71 038
+7%
|
71 112
+0%
|
80 707
+13%
|
78 247
-3%
|
136 566
+75%
|
135 486
-1%
|
114 100
-16%
|
101 525
-11%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
4 021
|
3 522
|
3 135
|
4 046
|
4 016
|
5 111
|
5 481
|
8 335
|
6 450
|
10 888
|
8 603
|
11 428
|
5 009
|
|
| Accrued Liabilities |
749
|
715
|
892
|
652
|
809
|
0
|
712
|
807
|
846
|
965
|
374
|
1 243
|
404
|
|
| Short-Term Debt |
0
|
385
|
385
|
100
|
55
|
66
|
42
|
138
|
143
|
230
|
163
|
674
|
3 450
|
|
| Current Portion of Long-Term Debt |
1 725
|
1 734
|
6 168
|
6 543
|
1 834
|
4 031
|
1 673
|
34
|
233
|
291
|
17 437
|
5 718
|
157
|
|
| Other Current Liabilities |
5 742
|
2 458
|
2 674
|
3 204
|
4 223
|
3 724
|
4 855
|
6 415
|
5 861
|
12 434
|
19 786
|
8 967
|
4 615
|
|
| Total Current Liabilities |
12 237
|
8 812
|
13 254
|
14 545
|
10 937
|
12 933
|
12 762
|
15 729
|
13 533
|
24 808
|
46 365
|
28 030
|
13 634
|
|
| Long-Term Debt |
4 744
|
7 382
|
1 294
|
1 670
|
2 334
|
1 673
|
0
|
86
|
379
|
15 217
|
185
|
323
|
73
|
|
| Minority Interest |
0
|
455
|
469
|
1 026
|
1 088
|
1 305
|
1 551
|
1 555
|
1 463
|
1 642
|
4 382
|
2 177
|
2 980
|
|
| Other Liabilities |
2 344
|
2 627
|
3 027
|
3 561
|
3 507
|
3 633
|
3 081
|
3 630
|
2 952
|
20 039
|
152
|
508
|
945
|
|
| Total Liabilities |
19 325
N/A
|
19 276
0%
|
18 043
-6%
|
20 802
+15%
|
17 866
-14%
|
19 544
+9%
|
17 395
-11%
|
20 999
+21%
|
18 327
-13%
|
61 705
+237%
|
51 083
-17%
|
31 037
-39%
|
17 632
-43%
|
|
| Equity | ||||||||||||||
| Common Stock |
2 300
|
2 500
|
2 600
|
2 836
|
2 986
|
3 225
|
3 450
|
3 750
|
4 000
|
4 150
|
4 250
|
4 350
|
4 450
|
|
| Retained Earnings |
21 910
|
25 148
|
26 622
|
27 515
|
30 716
|
31 986
|
33 309
|
40 280
|
44 024
|
58 805
|
68 475
|
67 177
|
69 170
|
|
| Additional Paid In Capital |
13 056
|
13 166
|
13 820
|
15 334
|
14 638
|
16 703
|
16 436
|
17 836
|
17 836
|
17 836
|
17 836
|
17 836
|
17 666
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
322
|
0
|
0
|
0
|
0
|
3 523
|
3 552
|
3 552
|
3 552
|
|
| Treasury Stock |
0
|
654
|
7
|
22
|
68
|
97
|
132
|
2 812
|
2 981
|
3 062
|
3 261
|
3 404
|
4 496
|
|
| Other Equity |
37
|
356
|
359
|
360
|
654
|
322
|
654
|
654
|
2 959
|
654
|
654
|
654
|
654
|
|
| Total Equity |
37 303
N/A
|
41 111
+10%
|
42 675
+4%
|
45 302
+6%
|
48 604
+7%
|
51 494
+6%
|
53 717
+4%
|
59 708
+11%
|
59 920
+0%
|
74 861
+25%
|
84 403
+13%
|
83 063
-2%
|
83 893
+1%
|
|
| Total Liabilities & Equity |
56 628
N/A
|
60 387
+7%
|
60 718
+1%
|
66 104
+9%
|
66 470
+1%
|
71 038
+7%
|
71 112
+0%
|
80 707
+13%
|
78 247
-3%
|
136 566
+75%
|
135 486
-1%
|
114 100
-16%
|
101 525
-11%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
7
|
9
|
8
|
8
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
|
Switch to:
Switch to:
See Also
Discover More
